Medicinal Cannabis

Despite a lack of “gold standard” evidence surrounding cannabis use for musculoskeletal pain, rheumatologists must not turn a blind eye to how such products are used by their patients in the real world, according to researchers.

Healio | Cardiology Today compiled a list of the top headlines in cardiology of January 2024.

The prevalence of medical cannabis use in the United States has increased significantly from 2013 to 2020, according to study results published in the American Journal of Preventive Medicine.

Jason S. Ng, OD, PhD, FAAO, spoke about key takeaways from his presentation at Academy on cannabis use and its effect on vision in a video interview with Healio.

The role and status of cannabis in the United States have evolved both medically and legally. In 2020, 49.6 million people in the United States reported using a form of cannabis in the previous year.

Medical cannabis dispensary workers such as budtenders, managers and pharmacists often made recommendations on cannabis use to customers based on their personal or coworkers’ experience, according to findings published in JAMA Network Open.

Cannabis strains that contain mostly cannabidiol and almost no tetrahydrocannabinol were not significantly associated with impaired driving, according to research published in JAMA.

A “revolution” in legal access to cannabis over the past 20 years has raised concerns about its overuse, researchers wrote in a review published in Annals of Internal Medicine.

A clinical trial recently launched in Canada is the first of its kind to collect real-world data on the use of validated medical cannabis products.

Many patients with MS turn to complementary treatment to help alleviate their symptoms. The National MS Society states that most patients in the United States incorporate complementary treatment as part of their disease management.